Life Sciences 1995-01-01

Antioxidation of human low density lipoprotein by morin hydrate.

T W Wu, K P Fung, C C Yang, R D Weisel

Index: Life Sci. 57 , PL51-PL56, (1995)

Full Text: HTML

Abstract

Oxidative modification of low density lipoprotein (LDL) has been suggested to be a risk factor for the development of atherosclerosis. Agents which can protect LDL from oxidation may be useful in preventing atherogenesis. Here, we found that morin hydrate, at 100 microM concentration, effectively inhibits Cu(2+)-induced oxidation of LDL. The oxidation of LDL was assessed by agarose gel electrophoresis. This was further studied by measuring the increased values of the malondialdehyde equivalents and the decreased numbers of reactive amino groups on oxidized LDL. Trolox, at equimolar concentrations, exhibit similar effects in preventing oxidation of LDL.

Related Compounds

  • morin r. g.

Related Articles:

A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin.

2014-11-19

[Sci. Transl. Med. 6(263) , 263ra161, (2014)]

Morin hydrate augments phagocytosis mechanism and inhibits LPS induced autophagic signaling in murine macrophage.

2014-10-01

[Int. Immunopharmacol. 22(2) , 356-65, (2014)]

Drug screening boosted by hyperpolarized long-lived states in NMR.

2014-11-01

[ChemMedChem 9(11) , 2509-15, (2014)]

Al adjuvants can be tracked in viable cells by lumogallion staining.

2015-07-01

[J. Immunol. Methods 422 , 87-94, (2015)]

Molecular properties and myocardial salvage effects of morin hydrate.

1995-02-14

[Biochem. Pharmacol. 49 , 537-543, (1995)]

More Articles...